TORONTO, ONTARIO — (Marketwired) — 06/01/17 — The common shares of Supreme Pharmaceuticals Inc. will be delisted at the market close, June 5, 2017.
Supreme Pharmaceuticals will continue to trade on the TSX Venture Exchange.
Date: Market close, June 5, 2017
Symbol: SL
Contacts:
Canadian Securities Exchange (CSE)
Listings
(416) 367-7340